03/29/2017 2:50 am EST


Todd Shaver

Founder and Editor-in-Chief, BullMarket.com

Israel-based Mazor Robotics (MZOR) has teamed up with Dublin, Ireland-based Medtronic (MDT) to co-market and promote the Mazor X. 

Mazor X expands on the company’s robotic guidance technology to include analytical tools, multiple-source data, precision guidance, optical tracking, intra-op verification and connectivity technologies. That is a lot of jargon, but we tell you this so that you know that Mazor X is a key technology for spine surgery.

Mazor is at a key inflection point, in our view, having generated record sales in the most recent quarter. Specifically, the 21 systems ordered during the most recent quarter illustrated strong ongoing demand – strong news on the fundamentals.

What is more exciting is that there is a clear and significant shift toward direct orders for the Mazor X system. Importantly, of the 21 systems currently in backlog, 18 are for Mazor X and only six of those are from Medtronic. 

This indicates significant bottom-up demand from surgeons. The Medtronic partnership is a good starting point, but the business is picking up momentum on its own. What is harder to do than spine surgery? Mazor is a top player in the space that is delivering on growth. We see compelling value in the stock.

Subscribe to Todd Shaver's Bullmarket.com here…

Related Articles on HEALTHCARE

Keyword Image
Merck: Dividends from Drugs
09/18/2018 5:00 am EST

Headquartered in New Jersey and founded in 1891, Merck & Co. (MRK) is a global health care compa...